(Q39134353)
Statements
1 reference
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab (English)
1 reference
1 reference
Mike F Burbridge
1 reference
Céline J Bossard
1 reference
Carine Saunier
1 reference
Imre Fejes
1 reference
Alain Bruno
1 reference
Stéphane Léonce
1 reference
Gilles Ferry
1 reference
Georges Da Violante
1 reference
François Bouzom
1 reference
Valérie Cattan
1 reference
Anne Jacquet-Bescond
1 reference
Brian P Lockhart
1 reference
Alex Cordi
1 reference
Jean-Claude Ortuno
1 reference
Alain Pierré
1 reference
John A Hickman
1 reference
Francisco H Cruzalegui
1 reference
Stéphane Depil
1 reference
26 June 2013
1 reference
1 reference
12
1 reference
9
1 reference
1749-1762
1 reference
1 reference
Identifiers
1 reference
1 reference